Showing results (471-480 of 811) with videos related to
Sort By:
Pageof 82
European Journal of Gastroenterology & Hepatology|December 7, 2016
The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control studyLukas W Unger, Merima Herac, Katharina Staufer, et al.Endoscopy|November 21, 2014
High quality of screening colonoscopy in Austria is not dependent on endoscopist specialty or settingKarin Kozbial, Karoline Reinhart, Georg Heinze, et al.United European Gastroenterology Journal|December 15, 2017
The role of TIPS in the management of liver transplant candidatesLukas W Unger, Theresa Stork, Theresa Bucsics, et al.Investigative Radiology|June 17, 2017
Effects of Portal Hypertension on Gadoxetic Acid-Enhanced Liver Magnetic Resonance: Diagnostic and Prognostic ImplicationsUlrika Asenbaum, Ahmed Ba-Ssalamah, Mattias Mandorfer, et al.AIDS Patient Care and Stds|May 9, 2019
Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV EradicationDavid Chromy, Mattias Mandorfer, Theresa Bucsics, et al.Journal of Gastroenterology|December 14, 2019
The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosisRémy Schwarzer, Thomas Reiberger, Mattias Mandorfer, et al.Medical Oncology (Northwood, London, England)|August 14, 2014
Sex is a stronger predictor of colorectal adenoma and advanced adenoma than fecal occult blood testMonika Ferlitsch, Georg Heinze, Petra Salzl, et al.Medicine|July 12, 2016
Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective studyBernhard Scheiner, Philipp Schwabl, Sebastian Steiner, et al.Der Pathologe|February 12, 2021
[Systemic consequences and clinical aspects of SARS-CoV-2 infection]Sigurd F Lax, Kristijan Skok, Peter M Zechner, et al.AIDS Patient Care and Stds|May 7, 2014
Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C co-infected patients in a real-world settingMattias Mandorfer, Berit A Payer, Alexander Niederecker, et al.Pageof 82